Dr. Michelle Mierzwa, M.D.
Claim this profileUniversity of Michigan Rogel Cancer Center
Studies Oropharyngeal Cancer
Studies Squamous Cell Carcinoma
4 reported clinical trials
10 drugs studied
Area of expertise
1Oropharyngeal Cancer
p16 positive
Stage I
Stage II
2Squamous Cell Carcinoma
p16 positive
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Michelle Mierzwa, M.D. is currently running
Personalized De-escalation Treatment
for Oropharyngeal Cancer
Single center, non-randomized Phase II study enrolling Stage I-II p16+ oropharyngeal cancer patients to one of two de-escalation treatment paradigms: (1) receive surgery followed by observation or risk-adjusted adjuvant radiation (+/-chemo), or (2) individualized adaptive definitive chemoradiation (CRT).
Recruiting1 award Phase 2
Chemotherapy + Radiation
for Oropharyngeal Cancer
This study seeks to study the population of HPV-related oropharynx cancer patients that appear to be at highest risk for treatment failure with loco-regional failure and distant metastases including cT4 or cN3. The study team aims to determine if it is feasible to use multi-modality imaging (both DCE MRI and FDG-PET) to optimize the radiation boost in high risk p16+ OPSCC with similar or decreased toxicity compared to historic standard therapy.
Recruiting1 award Phase 28 criteria
More about Michelle Mierzwa, M.D.
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michelle Mierzwa, M.D. has experience with
- Paclitaxel
- Carboplatin
- Radiation Therapy
- Nivolumab
- Platinum-based Chemotherapy
- Radiation
Breakdown of trials Michelle Mierzwa, M.D. has run
Oropharyngeal Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michelle Mierzwa, M.D. specialize in?
Michelle Mierzwa, M.D. focuses on Oropharyngeal Cancer and Squamous Cell Carcinoma. In particular, much of their work with Oropharyngeal Cancer has involved p16 positive patients, or patients who are Stage I.
Is Michelle Mierzwa, M.D. currently recruiting for clinical trials?
Yes, Michelle Mierzwa, M.D. is currently recruiting for 2 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Michelle Mierzwa, M.D. has studied deeply?
Yes, Michelle Mierzwa, M.D. has studied treatments such as Paclitaxel, Carboplatin, Radiation Therapy.
What is the best way to schedule an appointment with Michelle Mierzwa, M.D.?
Apply for one of the trials that Michelle Mierzwa, M.D. is conducting.
What is the office address of Michelle Mierzwa, M.D.?
The office of Michelle Mierzwa, M.D. is located at: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Rogel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.